Key Regulatory Elements of the TGFβ-LRRC15 Axis Predict Disease Progression and Immunotherapy Resistance Across

Insights

Transforming growth factor-beta (TGFβ) drives cancer progression by upregulating LRRC15. Identifying key genes like MMP2 and SPARC offers new immunotherapy targets for better cancer treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunology

Background:

  • Transforming growth factor-beta (TGFβ) exhibits complex roles in cancer, initially tumor-suppressive but later promoting metastasis and immune evasion.
  • Targeting TGFβ is challenging due to toxicity and broad immunosuppression.
  • Leucine-rich repeat-containing protein 15 (LRRC15) is a TGFβ-regulated antigen found on cancer cells and cancer-associated fibroblasts (CAFs), with its precise regulation by TGFβ being unclear.

Purpose of the Study:

  • To elucidate the molecular mechanisms by which TGFβ upregulates LRRC15 expression.
  • To identify key genomic regulators involved in TGFβ-induced LRRC15 expression.
  • To explore the potential of identified genes in predicting immunotherapy response.

Main Methods:

  • Integrated functional compound screening and single-cell RNA sequencing.
  • Construction of gene regulatory networks.
  • Validation in cell models.

Main Results:

  • Identified key genomic features regulating TGFβ-induced LRRC15 expression.
  • Gene regulatory network analysis pinpointed MMP2, SPARC, TGFβR2, and WNT5B as central regulators.
  • Validated the role of these genes in cell models.

Conclusions:

  • MMP2, SPARC, TGFβR2, and WNT5B are key mediators of TGFβ-induced LRRC15 pathobiology.
  • These genes hold potential for refining immunotherapy strategies.
  • Further research may enable personalized co-treatment options for cancer patients.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
951
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K